Clinical Trials Test MDMA as PTSD Treatment

Artwork credit: MDMA trial participant Allison Heistand-Phelps

Artwork credit: MDMA trial participant Allison Heistand-Phelps

This week on How on Earth host Susan Moran interviews two investigators of FDA-approved clinical trials testing the efficacy and safety of the illegal drug MDMA — known in an altered form as Ecstasy or Molly — as a treatment (along with psychotherapy sessions) for Post-Traumatic Stress Syndrome. Our guests are Marcela Ot’alora and Bruce Poulter, investigators of the Colorado trial. Marcela is a licensed psychotherapist and Bruce is a registered nurse with a masters degree in public health

PTSD is an anxiety disorder that affects up to one in 12 people in the United States, and it’s at least as common in some other countries. It is a serious, and costly, public health problem. If the trials are successful,  MDMA, which has its critics, could become commercially available as a medically prescribed treatment by 2021. The trials are being funded by a nonprofit organization, the Multidisciplinary Association for Psychedelic Studies (MAPS), which promotes careful and beneficial uses of psychedelics and marijuana.

Hosts: Susan Moran, Joel Parker
Producer: Susan Moran
Engineer: Joel Parker
Executive Producer: Joel Parker

Listen to the show:

Play
Share

Support KGNU


How On Earth is produced by a small group of volunteers at the studios of KGNU, an independent community radio station in the Boulder-Denver metro area. KGNU is supported by the generosity and efforts of community members like you. Visit kgnu.org to learn more.

Podcast

Subscribe via iTunes
 
How On Earth episodes can be downloaded as podcasts via iTunes, or streamed to a mobile device via Stitcher or Science360 Radio.
 
Listen on Stitcher
 
Listen on Science360 Radio
 
For more info about podcasting, and more subscription options, visit our Podcast page.